Literature DB >> 1054022

Editorial: New therapies for osteogenic sarcoma.

C J Campbell, J Cohen, W F Enneking.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 1054022

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN： 0021-9355            Impact factor:   5.284


× No keyword cloud information.
  5 in total

1.  Cryoimmunologic antitumor effects enhanced by dendritic cells in osteosarcoma.

Authors:  Masanori Kawano; Hideji Nishida; Yasunari Nakamoto; Hiroshi Tsumura; Hiroyuki Tsuchiya
Journal:  Clin Orthop Relat Res       Date:  2010-03-16       Impact factor: 4.176

2.  In vitro generation of cytotoxic T lymphocyte response using dendritic cell immunotherapy in osteosarcoma.

Authors:  Ye-Teng He; Qing-Min Zhang; Quan-Chun Kou; Bo Tang
Journal:  Oncol Lett       Date:  2016-06-15       Impact factor: 2.967

3.  Specific targeting of a naturally presented osteosarcoma antigen, papillomavirus binding factor peptide, using an artificial monoclonal antibody.

Authors:  Tomohide Tsukahara; Makoto Emori; Kenji Murata; Takahisa Hirano; Norihiro Muroi; Masanori Kyono; Shingo Toji; Kazue Watanabe; Toshihiko Torigoe; Vitaly Kochin; Hiroko Asanuma; Hiroshi Matsumiya; Keiji Yamashita; Tetsuo Himi; Shingo Ichimiya; Takuro Wada; Toshihiko Yamashita; Tadashi Hasegawa; Noriyuki Sato
Journal:  J Biol Chem       Date:  2014-06-24       Impact factor: 5.157

4.  A quest for therapeutic antigens in bone and soft tissue sarcoma.

Authors:  Satoshi Kawaguchi; Takuro Wada; Tomohide Tsukahara; Kazunori Ida; Toshihiko Torigoe; Noriyuki Sato; Toshihiko Yamashita
Journal:  J Transl Med       Date:  2005-08-08       Impact factor: 5.531

5.  HLA-A*0201-restricted CTL epitope of a novel osteosarcoma antigen, papillomavirus binding factor.

Authors:  Tomohide Tsukahara; Satoshi Kawaguchi; Toshihiko Torigoe; Akari Takahashi; Masaki Murase; Masanobu Kano; Takuro Wada; Mitsunori Kaya; Satoshi Nagoya; Toshihiko Yamashita; Noriyuki Sato
Journal:  J Transl Med       Date:  2009-06-12       Impact factor: 5.531
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.